SCHEMBL19080174

SCHEMBL19080174

c1ccc2c(c1)ccc1oc3cc(-c4ccc(-c5c6ccccc6c(-c6ccc7c(c6)sc6ccccc67)c6ccccc56)cc4)c4ccccc4c3c12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.35
MAPT P10636 2/20 0.35
ALDH1A1 P00352 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
ABCG2 Q9UNQ0 5/20 0.35
AHR P35869 3/20 0.35
PAX8 Q06710 2/20 0.35
NQO1 P15559 1/20 0.35
NQO2 P16083 1/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
TDP1 Q9NUW8 3/20 0.35
NPC1 O15118 2/20 0.35
GPR3 P46089 1/20 0.33
MEN1 O00255 1/20 0.33
TP53 P04637 1/20 0.33
CYP3A4 P08684 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20127721 0.87 ABCG2 (0.36) RAB9AMAPTABCG2AHRPAX8
SCHEMBL17944738 0.86 RAB9A (0.38) RAB9AMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL19076716 0.84 S1PR5 (0.33) MAPTABCG2CYP1A1TDP1MEN1
SCHEMBL19079983 0.83 ABCG2 (0.40) RAB9AMAPTABCG2AHRPAX8
SCHEMBL19080184 0.83 PAX8 (0.32) RAB9AMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL19079932 0.83 ABCG2 (0.49) RAB9AMAPTALDH1A1HPGDABCG2
SCHEMBL23427359 0.83 TDP1 (0.37) RAB9AMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL19080176 0.83 ARSA (0.35) MAPTALDH1A1HPGDABCG2CYP1A1
SCHEMBL19080158 0.83 TDP1 (0.41) RAB9AMAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL23427369 0.82 ABCG2 (0.40) RAB9AMAPTALDH1A1HPGDABCG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 RAB9A 2943/4885MAPT 1538/4885ALDH1A1 237/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 RAB9A 2943/4885MAPT 1538/4885ALDH1A1 237/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.